Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine

• Egile Nagusiak: Ruijin Qiu (Egilea), Chen Zhao (Egilea), Tengxiao Liang (Egilea), Xuezeng Hao (Egilea), Ya Huang (Egilea), Xiaoyu Zhang (Egilea), Zhao Chen (Egilea), Xuxu Wei (Egilea), Mengzhu Zhao (Egilea), Changming Zhong (Egilea), Jiayuan Hu (Egilea), Min Li (Egilea), Songjie Han (Egilea), Tianmai He (Egilea), Yang Sun (Egilea), Jing Chen (Egilea), Hongcai Shang (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

BackgroundDevelopment of a core outcome set (COS) for clinical trials for COVID-19 is urgent because of the pandemic wreaking havoc worldwide and the heterogeneity of outcomes in clinical trials.MethodsA preliminary list of outcomes was developed after a systematic review of protocols of clinical tr...